etisulergine has been researched along with pergolide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Closse, A; Frick, W; Jaton, A; Seiler, MP; Stoll, AP; Vigouret, JM | 1 |
| Nordmann, R; Petcher, TJ | 1 |
| Rinne, UK | 1 |
| Agnati, LF; Andersson, K; Fuxe, K; Hökfelt, T; Köhler, C; Kuonen, D; Ogren, SO | 1 |
4 other study(ies) available for etisulergine and pergolide
| Article | Year |
|---|---|
Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents.
Topics: Animals; Antiparkinson Agents; Binding Sites; Cattle; In Vitro Techniques; Naphthalenes; Rats; Receptors, Dopamine; Structure-Activity Relationship; Tetrahydronaphthalenes | 1986 |
Octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine.
Topics: Animals; Apomorphine; Ergolines; Female; Male; Pregnancy; Quinolines; Rats; Receptors, Dopamine; Structure-Activity Relationship | 1985 |
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Bromocriptine; Caudate Nucleus; Corpus Striatum; Ergolines; Kinetics; Organ Specificity; Pergolide; Putamen; Rats; Receptors, Dopamine | 1981 |